275 related articles for article (PubMed ID: 21535031)
1. Predictors of all-cause 1-year mortality in implantable cardioverter defibrillator patients with chronic Chagas' cardiomyopathy.
di Toro D; Muratore C; Aguinaga L; Batista L; Malan A; Greco O; Benchetrit C; Duque M; Baranchuk A; Maloney J
Pacing Clin Electrophysiol; 2011 Sep; 34(9):1063-9. PubMed ID: 21535031
[TBL] [Abstract][Full Text] [Related]
2. Predictors of all-cause mortality for patients with chronic Chagas' heart disease receiving implantable cardioverter defibrillator therapy.
Cardinalli-Neto A; Bestetti RB; Cordeiro JA; Rodrigues VC
J Cardiovasc Electrophysiol; 2007 Dec; 18(12):1236-40. PubMed ID: 17900257
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up of implantable cardioverter-defibrillator for secondary prevention in chagas' heart disease.
Martinelli M; de Siqueira SF; Sternick EB; Rassi A; Costa R; Ramires JA; Kalil Filho R
Am J Cardiol; 2012 Oct; 110(7):1040-5. PubMed ID: 22727179
[TBL] [Abstract][Full Text] [Related]
4. Implantable cardioverter defibrillators and Chagas' disease: results of the ICD Registry Latin America.
Muratore CA; Batista Sa LA; Chiale PA; Eloy R; Tentori MC; Escudero J; Lima AM; Medina LE; Garillo R; Maloney J
Europace; 2009 Feb; 11(2):164-8. PubMed ID: 19056745
[TBL] [Abstract][Full Text] [Related]
5. Left ventricular ejection fraction and absence of ACE inhibitor/angiotensin II receptor blocker predicts appropriate defibrillator therapy in the primary prevention population.
Obeyesekere MN; Chan W; Stub D; Prabhu S; Teo EP; Toogood G; Mariani J; Broughton A; Kistler PM
Pacing Clin Electrophysiol; 2010 Jun; 33(6):696-704. PubMed ID: 20059719
[TBL] [Abstract][Full Text] [Related]
6. Implantable cardioverter-defibrillators for treatment of sustained ventricular arrhythmias in patients with Chagas' heart disease: comparison with a control group treated with amiodarone alone.
Gali WL; Sarabanda AV; Baggio JM; Ferreira LG; Gomes GG; Marin-Neto JA; Junqueira LF
Europace; 2014 May; 16(5):674-80. PubMed ID: 24481778
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of QT interval parameters for mortality risk stratification in Chagas' disease: results of a long-term follow-up study.
Salles G; Xavier S; Sousa A; Hasslocher-Moreno A; Cardoso C
Circulation; 2003 Jul; 108(3):305-12. PubMed ID: 12835217
[TBL] [Abstract][Full Text] [Related]
8. Predictors of all-cause mortality in chronic Chagas' heart disease in the current era of heart failure therapy.
Theodoropoulos TA; Bestetti RB; Otaviano AP; Cordeiro JA; Rodrigues VC; Silva AC
Int J Cardiol; 2008 Aug; 128(1):22-9. PubMed ID: 18258318
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study.
Salerno-Uriarte JA; De Ferrari GM; Klersy C; Pedretti RF; Tritto M; Sallusti L; Libero L; Pettinati G; Molon G; Curnis A; Occhetta E; Morandi F; Ferrero P; Accardi F;
J Am Coll Cardiol; 2007 Nov; 50(19):1896-904. PubMed ID: 17980258
[TBL] [Abstract][Full Text] [Related]
10. Right ventricular dysfunction is an independent predictor of survival in patients with dilated chronic Chagas' cardiomyopathy.
Nunes Mdo C; Rocha MO; Ribeiro AL; Colosimo EA; Rezende RA; Carmo GA; Barbosa MM
Int J Cardiol; 2008 Jul; 127(3):372-9. PubMed ID: 17689706
[TBL] [Abstract][Full Text] [Related]
11. Re: Predictors of all-cause mortality for patients with chronic Chagas' heart disease receiving implantable cardioverter defibrillator therapy.
Cardinalli-Neto A; Bestetti RB; Cordeiro JA
J Cardiovasc Electrophysiol; 2008 Apr; 19(4):E34-5. PubMed ID: 18298517
[No Abstract] [Full Text] [Related]
12. Impact of left ventricular ejection fraction on occurrence of ventricular events in defibrillator patients with coronary artery disease.
Schaer B; Sticherling C; Szili-Torok T; Osswald S; Jordaens L; Theuns DA
Europace; 2011 Nov; 13(11):1562-7. PubMed ID: 21712284
[TBL] [Abstract][Full Text] [Related]
13. Predictors of death and occurrence of appropriate implantable defibrillator therapies in patients with ischemic cardiomyopathy.
Ng AC; Bertini M; Borleffs CJ; Delgado V; Boersma E; Piers SR; Thijssen J; Nucifora G; Shanks M; Ewe SH; Biffi M; van de Veire NR; Leung DY; Schalij MJ; Bax JJ
Am J Cardiol; 2010 Dec; 106(11):1566-73. PubMed ID: 21094356
[TBL] [Abstract][Full Text] [Related]
14. Predictors of mortality and heart transplantation in patients with Chagas' cardiomyopathy and ventricular tachycardia treated with implantable cardioverter-defibrillators.
Gali WL; Sarabanda AV; Baggio JM; Silva EF; Gomes GG; Junqueira LF
Europace; 2019 Jul; 21(7):1070-1078. PubMed ID: 30820579
[TBL] [Abstract][Full Text] [Related]
15. Cardiac remodeling and predictors for cardiac death in long-term follow-up of subjects with chronic Chagas' heart disease: a mathematical model for progression of myocardial damage.
Benchimol-Barbosa PR
Int J Cardiol; 2009 Jan; 131(3):435-8. PubMed ID: 18053595
[TBL] [Abstract][Full Text] [Related]
16. [14-year experience with implantable cardioverter/defibrillators: determination of prognosis and discharge behavior].
Vester EG; Dees H; Dobran I; Hennersdorf M; Perings C; Heydthausen M; Winter J; Strauer BE
Z Kardiol; 2000; 89 Suppl 3():194-205. PubMed ID: 10810803
[TBL] [Abstract][Full Text] [Related]
17. Relation of interatrial block to new-onset atrial fibrillation in patients with Chagas cardiomyopathy and implantable cardioverter-defibrillators.
Enriquez A; Conde D; Femenia F; de Luna AB; Ribeiro A; Muratore C; Valentino M; Retyk E; Galizio N; Hopman WM; Baranchuk A
Am J Cardiol; 2014 May; 113(10):1740-3. PubMed ID: 24698463
[TBL] [Abstract][Full Text] [Related]
18. Lower body mass index and atrial fibrillation as independent predictors for mortality in patients with implantable cardioverter defibrillator.
Schernthaner C; Pichler M; Strohmer B
Croat Med J; 2007 Feb; 48(1):59-67. PubMed ID: 17309140
[TBL] [Abstract][Full Text] [Related]
19. The role of implantable cardioverter defibrillator for primary vs secondary prevention of sudden death in patients with idiopathic dilated cardiomyopathy.
Zecchin M; Di Lenarda A; Proclemer A; Faganello G; Facchin D; Petz E; Sinagra G
Europace; 2004 Sep; 6(5):400-6. PubMed ID: 15294264
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of implantable defibrillators in octogenarians and nonagenarians for primary prevention of sudden cardiac death.
Mezu U; Adelstein E; Jain S; Saba S
Am J Cardiol; 2011 Sep; 108(5):718-22. PubMed ID: 21640321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
